Skip to main content

PREGABALIN

NDC 72658-0813 · Eskayef Pharmaceuticals Limited

Generic namePREGABALIN
Dosage formCAPSULE
RouteORAL
Active ingredient(s)PREGABALIN
Strength225 mg/1
DEA scheduleCV
Marketing categoryANDA

Packages

72658-0813-1 — 60 CAPSULE in 1 BOTTLE (72658-0813-1)

72658-0813-2 — 90 CAPSULE in 1 BOTTLE (72658-0813-2)

72658-0813-6 — 500 CAPSULE in 1 BOTTLE (72658-0813-6)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

72603-354 — Pregabalin, 72603-355 — Pregabalin, 72603-356 — Pregabalin, 72603-357 — Pregabalin, 72603-358 — Pregabalin, 72658-0808 — PREGABALIN, 72658-0809 — PREGABALIN, 72658-0810 — PREGABALIN, 72658-0811 — PREGABALIN, 72658-0812 — PREGABALIN, 72658-0814 — PREGABALIN, 72658-0849 — PREGABALIN, 72888-049 — Pregabalin, 72888-050 — Pregabalin, 72888-051 — Pregabalin, 73190-053 — Pregabalin, 73190-054 — Pregabalin, 73190-055 — Pregabalin, 73190-056 — Pregabalin, 73190-057 — Pregabalin, +519 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels